Comparing Ahmed-FP7 to Baerveldt-250 and Baerveldt-350 surgical outcomes: 1-year results from a retrospective cohort study leveraging the electronic health record

ObjectiveTo compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and analysisRetrospective cohort study comprising 800 eyes from 800 individuals who underwent surgery 1 January 2016–31 December 2020 at a tertiary-care institut...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open ophthalmology Vol. 8; no. 1; p. e001308
Main Authors: Shen, Leo L, Guo, Xinxing, Johnson, Thomas V, Friedman, David, Boland, Michael V, McGlumphy, Elyse J
Format: Journal Article
Language:English
Published: England BMJ Publishing Group Ltd 01-06-2023
BMJ Publishing Group LTD
BMJ Publishing Group
Series:Original research
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract ObjectiveTo compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and analysisRetrospective cohort study comprising 800 eyes from 800 individuals who underwent surgery 1 January 2016–31 December 2020 at a tertiary-care institution. Data were extracted from standardised fields in the electronic health record. Primary outcome was failure (defined as intraocular pressure (IOP) ≤5 mm Hg or >18 mm Hg or reduction <20% at two consecutive visits from month 3 onwards; or visual acuity (VA) loss ≥3 lines; or return to the operating room (OR)). Secondary outcomes were IOP, VA, number of follow-up visits and return to the OR.ResultsA total of 523 AGI-FP7, 133 BGI-250 and 144 BGI-350 cases were analysed. The AGI-FP7 group was more likely to be younger and diagnosed with secondary glaucoma, with a higher mean baseline IOP (28.5±12.2 vs 22.0±7.7 mm Hg in BGI-250 and 23.4±9.0 in BGI-350, p<0.001). Cumulative failure rate at month 12 was 30% (AGI-FP7) vs 39% (BGI-250) vs 33% (BGI-350, p=0.159). Mean IOP at month 12 was lower in the BGI-350 group compared with AGI-FP7 (12.4±4.4 vs 14.8±5.6 mm Hg, p=0.003) but not BGI-250 (vs 13.1±4.6, p=0.710). Target IOP was achieved in 71% of AGI-FP7, 66% BGI-250, and 76% BGI-350. VA loss and rates of return to the OR did not differ between groups. Both BGI-250 and BGI-350 had more follow-up visits than AGI-FP7 (p<0.001).ConclusionThese three glaucoma drainage devices performed similarly within 1 year, with no difference in failure rates despite differing baseline patient characteristics.
AbstractList To compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm (BGI-250), or Baerveldt-350mm (BGI-350) implantation. Retrospective cohort study comprising 800 eyes from 800 individuals who underwent surgery 1 January 2016-31 December 2020 at a tertiary-care institution. Data were extracted from standardised fields in the electronic health record. Primary outcome was failure (defined as intraocular pressure (IOP) ≤5 mm Hg or >18 mm Hg or reduction <20% at two consecutive visits from month 3 onwards; or visual acuity (VA) loss ≥3 lines; or return to the operating room (OR)). Secondary outcomes were IOP, VA, number of follow-up visits and return to the OR. A total of 523 AGI-FP7, 133 BGI-250 and 144 BGI-350 cases were analysed. The AGI-FP7 group was more likely to be younger and diagnosed with secondary glaucoma, with a higher mean baseline IOP (28.5±12.2 vs 22.0±7.7 mm Hg in BGI-250 and 23.4±9.0 in BGI-350, p<0.001). Cumulative failure rate at month 12 was 30% (AGI-FP7) vs 39% (BGI-250) vs 33% (BGI-350, p=0.159). Mean IOP at month 12 was lower in the BGI-350 group compared with AGI-FP7 (12.4±4.4 vs 14.8±5.6 mm Hg, p=0.003) but not BGI-250 (vs 13.1±4.6, p=0.710). Target IOP was achieved in 71% of AGI-FP7, 66% BGI-250, and 76% BGI-350. VA loss and rates of return to the OR did not differ between groups. Both BGI-250 and BGI-350 had more follow-up visits than AGI-FP7 (p<0.001). These three glaucoma drainage devices performed similarly within 1 year, with no difference in failure rates despite differing baseline patient characteristics.
ObjectiveTo compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and analysisRetrospective cohort study comprising 800 eyes from 800 individuals who underwent surgery 1 January 2016–31 December 2020 at a tertiary-care institution. Data were extracted from standardised fields in the electronic health record. Primary outcome was failure (defined as intraocular pressure (IOP) ≤5 mm Hg or >18 mm Hg or reduction <20% at two consecutive visits from month 3 onwards; or visual acuity (VA) loss ≥3 lines; or return to the operating room (OR)). Secondary outcomes were IOP, VA, number of follow-up visits and return to the OR.ResultsA total of 523 AGI-FP7, 133 BGI-250 and 144 BGI-350 cases were analysed. The AGI-FP7 group was more likely to be younger and diagnosed with secondary glaucoma, with a higher mean baseline IOP (28.5±12.2 vs 22.0±7.7 mm Hg in BGI-250 and 23.4±9.0 in BGI-350, p<0.001). Cumulative failure rate at month 12 was 30% (AGI-FP7) vs 39% (BGI-250) vs 33% (BGI-350, p=0.159). Mean IOP at month 12 was lower in the BGI-350 group compared with AGI-FP7 (12.4±4.4 vs 14.8±5.6 mm Hg, p=0.003) but not BGI-250 (vs 13.1±4.6, p=0.710). Target IOP was achieved in 71% of AGI-FP7, 66% BGI-250, and 76% BGI-350. VA loss and rates of return to the OR did not differ between groups. Both BGI-250 and BGI-350 had more follow-up visits than AGI-FP7 (p<0.001).ConclusionThese three glaucoma drainage devices performed similarly within 1 year, with no difference in failure rates despite differing baseline patient characteristics.
Objective To compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and analysis Retrospective cohort study comprising 800 eyes from 800 individuals who underwent surgery 1 January 2016–31 December 2020 at a tertiary-care institution. Data were extracted from standardised fields in the electronic health record. Primary outcome was failure (defined as intraocular pressure (IOP) ≤5 mm Hg or >18 mm Hg or reduction <20% at two consecutive visits from month 3 onwards; or visual acuity (VA) loss ≥3 lines; or return to the operating room (OR)). Secondary outcomes were IOP, VA, number of follow-up visits and return to the OR.Results A total of 523 AGI-FP7, 133 BGI-250 and 144 BGI-350 cases were analysed. The AGI-FP7 group was more likely to be younger and diagnosed with secondary glaucoma, with a higher mean baseline IOP (28.5±12.2 vs 22.0±7.7 mm Hg in BGI-250 and 23.4±9.0 in BGI-350, p<0.001). Cumulative failure rate at month 12 was 30% (AGI-FP7) vs 39% (BGI-250) vs 33% (BGI-350, p=0.159). Mean IOP at month 12 was lower in the BGI-350 group compared with AGI-FP7 (12.4±4.4 vs 14.8±5.6 mm Hg, p=0.003) but not BGI-250 (vs 13.1±4.6, p=0.710). Target IOP was achieved in 71% of AGI-FP7, 66% BGI-250, and 76% BGI-350. VA loss and rates of return to the OR did not differ between groups. Both BGI-250 and BGI-350 had more follow-up visits than AGI-FP7 (p<0.001).Conclusion These three glaucoma drainage devices performed similarly within 1 year, with no difference in failure rates despite differing baseline patient characteristics.
Author Guo, Xinxing
Shen, Leo L
Friedman, David
Boland, Michael V
McGlumphy, Elyse J
Johnson, Thomas V
Author_xml – sequence: 1
  givenname: Leo L
  orcidid: 0000-0002-9563-6276
  surname: Shen
  fullname: Shen, Leo L
  organization: Ophthalmology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA
– sequence: 2
  givenname: Xinxing
  surname: Guo
  fullname: Guo, Xinxing
  organization: Ophthalmology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA
– sequence: 3
  givenname: Thomas V
  surname: Johnson
  fullname: Johnson, Thomas V
  organization: Ophthalmology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA
– sequence: 4
  givenname: David
  surname: Friedman
  fullname: Friedman, David
  organization: Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA
– sequence: 5
  givenname: Michael V
  surname: Boland
  fullname: Boland, Michael V
  organization: Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA
– sequence: 6
  givenname: Elyse J
  surname: McGlumphy
  fullname: McGlumphy, Elyse J
  email: elysejoelle@gmail.com
  organization: Ophthalmology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37493661$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_oP0DIEhcuAX_FjrmgsmqhUiU4wNmadSabrJJ4sZ2V9u_wS_Gybdly4GR7_Mw7nvF7XpxMfsKieMXoO8aEer8c137Tpa7klIuSUiZo_aw448LoUnBlTo72p8VljGuaIcOU5OpFcSq0NEIpdlb8WvhxA6GfVuSqG7Epb75pkjz5BBi2ODSp5BUlMDVHEZEjcQ6r3sFA_JycHzF-IKzcIQQSMM5DiqQNfiSQjyn4uEGX-i0S5zsfEolpbnZkwC0GWO1rpw4JDhkKfuod6RCG1OVc50PzsnjewhDx8n69KH7cXH9ffCnvvn6-XVzdlcvcTCrBAGDLaqXrytFWmVaLWiFzmrUGZA2iMk3VSF4rBdDoqq2olNy1TIFjWouL4vag23hY203oRwg766G3fwI-rCyE1LsBba1YbbiuNJVc5vLGSb5sGlohRZV_JGt9PGht5mWeqsMpBRieiD69mfrOrvzWMioZrVWdFd7eKwT_c8aY7NhHh8MAE_o5Wl7n0hUXlczom3_QtZ_DlGeVKW6kFNSYTMkD5fJ_xIDt42sYtXtT2QdT2b2p7MFUOe31cSePSQ8WygA9ADn9b-H_av4GP7vcEg
Cites_doi 10.1016/j.ophtha.2013.04.018
10.1016/j.ophtha.2007.10.034
10.1016/j.ophtha.2014.09.002
10.1016/S0002-9394(98)00272-4
10.1016/j.ophtha.2011.05.004
10.1001/archopht.120.6.701
10.3928/15428877-20110224-94
10.1016/j.ophtha.2014.08.043
10.18240/ijo.2020.12.10
10.1016/j.ophtha.2006.02.029
10.4103/0974-9233.56219
10.21873/invivo.11558
10.1016/s0161-6420(95)30871-8
10.1097/IJG.0000000000001583
10.1097/IJG.0000000000002136
10.2147/OPTH.S80490
10.1016/j.survophthal.2004.10.006
10.1016/s0161-6420(95)30904-9
10.1016/S0002-9394(00)00538-9
10.1001/jama.2020.21899
10.3109/08820538.2010.518840
10.1016/s0161-6420(96)30700-8
10.1016/j.ajo.2017.01.003
10.1097/00061198-200402000-00008
10.1016/S0161-6420(03)00574-8
10.5694/mja2.50020
10.1016/j.ophtha.2010.07.016
10.1097/ICU.0000000000000549
10.1001/archopht.120.10.1268
10.1136/bjo.85.6.689
10.5005/jp-journals-10008-1215
10.1016/j.ajo.2017.11.019
10.1186/s12886-016-0265-6
10.3928/15428877-20110224-04
10.1016/S0161-6420(95)30904-9
10.1016/S0161-6420(96)30700-8
10.1016/S0161-6420(95)30871-8
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023
Copyright_xml – notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023
DBID 9YT
ACMMV
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1136/bmjophth-2023-001308
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest One Academic Eastern Edition

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2397-3269
ExternalDocumentID oai_doaj_org_article_8618927570424b499c42bdd05e0e6023
10_1136_bmjophth_2023_001308
37493661
ttps://bmjophth.bmj.com/content/8/1/e001308.full
Genre Journal Article
GeographicLocations United States--US
California
GeographicLocations_xml – name: United States--US
– name: California
GrantInformation_xml – fundername: The Shelley and Alan Holt Professorship in Ophthalmology
– fundername: National Eye Institute
  grantid: K08-EY031801
  funderid: http://dx.doi.org/10.13039/100000053
– fundername: American Glaucoma Society
  funderid: http://dx.doi.org/10.13039/100007826
– fundername: Research to Prevent Blindness
  funderid: http://dx.doi.org/10.13039/100001818
– fundername: ;
– fundername: ;
  grantid: K08-EY031801
GroupedDBID 53G
5VS
7X7
8FI
8FJ
9YT
ABUWG
ACGFS
ACMMV
ADBBV
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BTFSW
CCPQU
FYUFA
GROUPED_DOAJ
H13
HMCUK
HYE
M~E
O9-
OK1
RHF
RHI
RMJ
RPM
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7XB
8FK
K9.
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-b493t-a9aaef186785c0f69f7386e1c71f9a48a359d5d42866aad75f50442cf16ac1773
IEDL.DBID RPM
ISSN 2397-3269
IngestDate Tue Oct 22 15:14:10 EDT 2024
Tue Sep 17 21:31:44 EDT 2024
Sat Aug 17 01:56:36 EDT 2024
Mon Nov 18 04:14:59 EST 2024
Thu Nov 21 21:41:32 EST 2024
Wed Oct 16 00:39:22 EDT 2024
Mon Sep 09 15:08:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Glaucoma
Vision
Treatment Surgery
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b493t-a9aaef186785c0f69f7386e1c71f9a48a359d5d42866aad75f50442cf16ac1773
Notes Original research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9563-6276
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410868/
PMID 37493661
PQID 2829443099
PQPubID 5161127
ParticipantIDs doaj_primary_oai_doaj_org_article_8618927570424b499c42bdd05e0e6023
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10410868
proquest_miscellaneous_2842452354
proquest_journals_2829443099
crossref_primary_10_1136_bmjophth_2023_001308
pubmed_primary_37493661
bmj_journals_10_1136_bmjophth_2023_001308
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Original research
PublicationTitle BMJ open ophthalmology
PublicationTitleAbbrev BMJ Open Ophth
PublicationTitleAlternate BMJ Open Ophthalmol
PublicationYear 2023
Publisher BMJ Publishing Group Ltd
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group Ltd
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Tsai, Johnson, Dietrich (R31) 2003; 110
(R1) 1998; 126
Sinha, Ganjei, McWatters (R24) 2020; 29
Syed, Law, Nam (R29) 2004; 13
Christakis, Tsai, Kalenak (R16) 2013; 120
Christakis, Kalenak, Zurakowski (R30) 2011; 118
Sidoti, Dunphy, Baerveldt (R18) 1995; 102
Moschos, Nitoda, Gouliopoulos (R27) 2019; 33
Chen, Gedde (R13) 2019; 30
Budenz, Barton, Gedde (R15) 2015; 122
Kass, Heuer, Higginbotham (R4) 2002; 120
Richter, Coleman (R8) 2016; 10
Wang, Gao, Qian (R26) 2016; 16
Stein, Khawaja, Weizer (R6) 2021; 325
Hong, Arosemena, Zurakowski (R7) 2005; 50
Patel, Pasquale (R10) 2010; 25
Kilgore, Grosinger, Liu (R23) 2023; 32
Christakis, Zhang, Budenz (R17) 2017; 176
Goulet, Phan, Cantor (R22) 2008; 115
Siegner, Netland, Urban (R19) 1995; 102
Lusthaus, Goldberg (R5) 2019; 210
Koentjoro, Artini, Soebijantoro (R25) 2020; 13
Allan, Khaimi, Jones (R33) 2015; 122
Broadway, Iester, Schulzer (R21) 2001; 85
Mills, Reynolds, Emond (R20) 1996; 103
Heijl, Leske, Bengtsson (R3) 2002; 120
(R2) 2000; 130
Budenz, Barton, Feuer (R14) 2011; 118
Yadgarov, Liu, Crane (R28) 2017; 11
Gedde (R12) 2009; 16
Serle, Katz, McLaurin (R9) 2018; 186
Desai, Gedde, Feuer (R11) 2011; 42
Tsai, Johnson, Kammer (R32) 2006; 113
Wang (2024051503452828000_8.1.e001308.26) 2016; 16
Sidoti (2024051503452828000_8.1.e001308.18) 1995; 102
2024051503452828000_8.1.e001308.27
2024051503452828000_8.1.e001308.21
2024051503452828000_8.1.e001308.22
Gedde (2024051503452828000_8.1.e001308.12) 2009; 16
2024051503452828000_8.1.e001308.7
2024051503452828000_8.1.e001308.6
2024051503452828000_8.1.e001308.8
2024051503452828000_8.1.e001308.3
2024051503452828000_8.1.e001308.2
2024051503452828000_8.1.e001308.5
2024051503452828000_8.1.e001308.4
Yadgarov (2024051503452828000_8.1.e001308.28) 2017; 11
Sinha (2024051503452828000_8.1.e001308.24) 2020; 29
2024051503452828000_8.1.e001308.1
Serle (2024051503452828000_8.1.e001308.9) 2018; 186
Chen (2024051503452828000_8.1.e001308.13) 2019; 30
2024051503452828000_8.1.e001308.14
2024051503452828000_8.1.e001308.15
Siegner (2024051503452828000_8.1.e001308.19) 1995; 102
2024051503452828000_8.1.e001308.31
Allan (2024051503452828000_8.1.e001308.33) 2015; 122
2024051503452828000_8.1.e001308.32
2024051503452828000_8.1.e001308.11
2024051503452828000_8.1.e001308.30
Christakis (2024051503452828000_8.1.e001308.17) 2017; 176
Koentjoro (2024051503452828000_8.1.e001308.25) 2020; 13
Christakis (2024051503452828000_8.1.e001308.16) 2013; 120
Patel (2024051503452828000_8.1.e001308.10) 2010; 25
Kilgore (2024051503452828000_8.1.e001308.23) 2023; 32
Mills (2024051503452828000_8.1.e001308.20) 1996; 103
2024051503452828000_8.1.e001308.29
References_xml – volume: 120
  start-page: 2232
  year: 2013
  ident: R16
  article-title: The Ahmed versus Baerveldt study: three-year treatment outcomes
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.04.018
  contributor:
    fullname: Kalenak
– volume: 115
  start-page: 1141
  year: 2008
  ident: R22
  article-title: Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2007.10.034
  contributor:
    fullname: Cantor
– volume: 122
  start-page: 486
  year: 2015
  ident: R33
  article-title: Long-term efficacy of the Baerveldt 250 mm2 compared with the Baerveldt 350 mm2 implant
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2014.09.002
  contributor:
    fullname: Jones
– volume: 126
  start-page: 498
  year: 1998
  ident: R1
  article-title: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(98)00272-4
– volume: 118
  start-page: 2180
  year: 2011
  ident: R30
  article-title: The Ahmed versus Baerveldt study: one-year treatment outcomes
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2011.05.004
  contributor:
    fullname: Zurakowski
– volume: 120
  start-page: 701
  year: 2002
  ident: R4
  article-title: The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.6.701
  contributor:
    fullname: Higginbotham
– volume: 42
  start-page: 202
  year: 2011
  ident: R11
  article-title: Practice preferences for glaucoma surgery: a survey of the American glaucoma society in 2008
  publication-title: Ophthalmic Surg Lasers Imaging
  doi: 10.3928/15428877-20110224-94
  contributor:
    fullname: Feuer
– volume: 122
  start-page: 308
  year: 2015
  ident: R15
  article-title: Five-year treatment outcomes in the Ahmed Baerveldt comparison study
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2014.08.043
  contributor:
    fullname: Gedde
– volume: 13
  start-page: 1908
  year: 2020
  ident: R25
  article-title: Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up
  publication-title: Int J Ophthalmol
  doi: 10.18240/ijo.2020.12.10
  contributor:
    fullname: Soebijantoro
– volume: 113
  start-page: 913
  year: 2006
  ident: R32
  article-title: The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.02.029
  contributor:
    fullname: Kammer
– volume: 16
  start-page: 107
  year: 2009
  ident: R12
  article-title: Results from the tube versus trabeculectomy study
  publication-title: Middle East Afr J Ophthalmol
  doi: 10.4103/0974-9233.56219
  contributor:
    fullname: Gedde
– volume: 33
  start-page: 911
  year: 2019
  ident: R27
  article-title: The choice of drainage device in complicated glaucomas: comparing Ahmed and Baerveldt implants
  publication-title: In Vivo
  doi: 10.21873/invivo.11558
  contributor:
    fullname: Gouliopoulos
– volume: 102
  start-page: 1298
  year: 1995
  ident: R19
  article-title: Clinical experience with the Baerveldt glaucoma drainage implant
  publication-title: Ophthalmology
  doi: 10.1016/s0161-6420(95)30871-8
  contributor:
    fullname: Urban
– volume: 29
  start-page: 750
  year: 2020
  ident: R24
  article-title: Ahmed versus Baerveldt glaucoma drainage device in uveitic glaucoma: a retrospective comparative study
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000001583
  contributor:
    fullname: McWatters
– volume: 32
  start-page: 210
  year: 2023
  ident: R23
  article-title: Comparing surgical and clinical success rates of Ahmed Fp7, and Baerveldt 250 and Baerveldt 350 glaucoma drainage devices
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000002136
  contributor:
    fullname: Liu
– volume: 10
  start-page: 189
  year: 2016
  ident: R8
  article-title: Minimally invasive glaucoma surgery: current status and future prospects
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S80490
  contributor:
    fullname: Coleman
– volume: 50
  start-page: 48
  year: 2005
  ident: R7
  article-title: Glaucoma drainage devices: a systematic literature review and current controversies
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2004.10.006
  contributor:
    fullname: Zurakowski
– volume: 102
  start-page: 1107
  year: 1995
  ident: R18
  article-title: Experience with the Baerveldt glaucoma implant in treating Neovascular glaucoma
  publication-title: Ophthalmology
  doi: 10.1016/s0161-6420(95)30904-9
  contributor:
    fullname: Baerveldt
– volume: 130
  start-page: 429
  year: 2000
  ident: R2
  article-title: The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00538-9
– volume: 325
  start-page: 164
  year: 2021
  ident: R6
  article-title: Glaucoma in adults—screening, diagnosis, and management: a review
  publication-title: JAMA
  doi: 10.1001/jama.2020.21899
  contributor:
    fullname: Weizer
– volume: 25
  start-page: 265
  year: 2010
  ident: R10
  article-title: Glaucoma drainage devices: a review of the past, present, and future
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2010.518840
  contributor:
    fullname: Pasquale
– volume: 103
  start-page: 299
  year: 1996
  ident: R20
  article-title: Long-term survival of Molteno glaucoma drainage devices
  publication-title: Ophthalmology
  doi: 10.1016/s0161-6420(96)30700-8
  contributor:
    fullname: Emond
– volume: 176
  start-page: 118
  year: 2017
  ident: R17
  article-title: Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2017.01.003
  contributor:
    fullname: Budenz
– volume: 13
  start-page: 38
  year: 2004
  ident: R29
  article-title: Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison
  publication-title: J Glaucoma
  doi: 10.1097/00061198-200402000-00008
  contributor:
    fullname: Nam
– volume: 110
  start-page: 1814
  year: 2003
  ident: R31
  article-title: The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(03)00574-8
  contributor:
    fullname: Dietrich
– volume: 210
  start-page: 180
  year: 2019
  ident: R5
  article-title: Current management of glaucoma
  publication-title: Med J Aust
  doi: 10.5694/mja2.50020
  contributor:
    fullname: Goldberg
– volume: 118
  start-page: 443
  year: 2011
  ident: R14
  article-title: Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2010.07.016
  contributor:
    fullname: Feuer
– volume: 30
  start-page: 125
  year: 2019
  ident: R13
  article-title: New developments in tube shunt surgery
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0000000000000549
  contributor:
    fullname: Gedde
– volume: 120
  start-page: 1268
  year: 2002
  ident: R3
  article-title: Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.10.1268
  contributor:
    fullname: Bengtsson
– volume: 85
  start-page: 689
  year: 2001
  ident: R21
  article-title: Survival analysis for success of Molteno tube implants
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.85.6.689
  contributor:
    fullname: Schulzer
– volume: 11
  start-page: 16
  year: 2017
  ident: R28
  article-title: Surgical outcomes of Ahmed or Baerveldt tube shunt implantation for medically uncontrolled traumatic glaucoma
  publication-title: J Curr Glaucoma Pract
  doi: 10.5005/jp-journals-10008-1215
  contributor:
    fullname: Crane
– volume: 186
  start-page: 116
  year: 2018
  ident: R9
  article-title: Two phase 3 clinical trials comparing the safety and efficacy of Netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2017.11.019
  contributor:
    fullname: McLaurin
– volume: 16
  start-page: 83
  year: 2016
  ident: R26
  article-title: The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-016-0265-6
  contributor:
    fullname: Qian
– ident: 2024051503452828000_8.1.e001308.11
  doi: 10.3928/15428877-20110224-04
– volume: 29
  start-page: 750
  year: 2020
  ident: 2024051503452828000_8.1.e001308.24
  article-title: Ahmed versus Baerveldt glaucoma drainage device in uveitic glaucoma: a retrospective comparative study
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000001583
  contributor:
    fullname: Sinha
– ident: 2024051503452828000_8.1.e001308.32
  doi: 10.1016/j.ophtha.2006.02.029
– ident: 2024051503452828000_8.1.e001308.31
  doi: 10.1016/S0161-6420(03)00574-8
– volume: 122
  start-page: 486
  year: 2015
  ident: 2024051503452828000_8.1.e001308.33
  article-title: Long-term efficacy of the Baerveldt 250 mm2 compared with the Baerveldt 350 mm2 implant
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2014.09.002
  contributor:
    fullname: Allan
– volume: 11
  start-page: 16
  year: 2017
  ident: 2024051503452828000_8.1.e001308.28
  article-title: Surgical outcomes of Ahmed or Baerveldt tube shunt implantation for medically uncontrolled traumatic glaucoma
  publication-title: J Curr Glaucoma Pract
  doi: 10.5005/jp-journals-10008-1215
  contributor:
    fullname: Yadgarov
– ident: 2024051503452828000_8.1.e001308.21
  doi: 10.1136/bjo.85.6.689
– volume: 102
  start-page: 1107
  year: 1995
  ident: 2024051503452828000_8.1.e001308.18
  article-title: Experience with the Baerveldt glaucoma implant in treating Neovascular glaucoma
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(95)30904-9
  contributor:
    fullname: Sidoti
– volume: 176
  start-page: 118
  year: 2017
  ident: 2024051503452828000_8.1.e001308.17
  article-title: Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2017.01.003
  contributor:
    fullname: Christakis
– ident: 2024051503452828000_8.1.e001308.27
  doi: 10.21873/invivo.11558
– ident: 2024051503452828000_8.1.e001308.22
  doi: 10.1016/j.ophtha.2007.10.034
– ident: 2024051503452828000_8.1.e001308.8
  doi: 10.2147/OPTH.S80490
– volume: 120
  start-page: 2232
  year: 2013
  ident: 2024051503452828000_8.1.e001308.16
  article-title: The Ahmed versus Baerveldt study: three-year treatment outcomes
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.04.018
  contributor:
    fullname: Christakis
– volume: 103
  start-page: 299
  year: 1996
  ident: 2024051503452828000_8.1.e001308.20
  article-title: Long-term survival of Molteno glaucoma drainage devices
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(96)30700-8
  contributor:
    fullname: Mills
– ident: 2024051503452828000_8.1.e001308.3
  doi: 10.1001/archopht.120.10.1268
– ident: 2024051503452828000_8.1.e001308.29
  doi: 10.1097/00061198-200402000-00008
– ident: 2024051503452828000_8.1.e001308.1
  doi: 10.1016/S0002-9394(98)00272-4
– volume: 32
  start-page: 210
  year: 2023
  ident: 2024051503452828000_8.1.e001308.23
  article-title: Comparing surgical and clinical success rates of Ahmed Fp7, and Baerveldt 250 and Baerveldt 350 glaucoma drainage devices
  publication-title: J Glaucoma
  doi: 10.1097/IJG.0000000000002136
  contributor:
    fullname: Kilgore
– volume: 102
  start-page: 1298
  year: 1995
  ident: 2024051503452828000_8.1.e001308.19
  article-title: Clinical experience with the Baerveldt glaucoma drainage implant
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(95)30871-8
  contributor:
    fullname: Siegner
– ident: 2024051503452828000_8.1.e001308.2
  doi: 10.1016/S0002-9394(00)00538-9
– volume: 186
  start-page: 116
  year: 2018
  ident: 2024051503452828000_8.1.e001308.9
  article-title: Two phase 3 clinical trials comparing the safety and efficacy of Netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2017.11.019
  contributor:
    fullname: Serle
– ident: 2024051503452828000_8.1.e001308.14
  doi: 10.1016/j.ophtha.2010.07.016
– ident: 2024051503452828000_8.1.e001308.4
  doi: 10.1001/archopht.120.6.701
– volume: 25
  start-page: 265
  year: 2010
  ident: 2024051503452828000_8.1.e001308.10
  article-title: Glaucoma drainage devices: a review of the past, present, and future
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2010.518840
  contributor:
    fullname: Patel
– volume: 16
  start-page: 107
  year: 2009
  ident: 2024051503452828000_8.1.e001308.12
  article-title: Results from the tube versus trabeculectomy study
  publication-title: Middle East Afr J Ophthalmol
  doi: 10.4103/0974-9233.56219
  contributor:
    fullname: Gedde
– ident: 2024051503452828000_8.1.e001308.30
  doi: 10.1016/j.ophtha.2011.05.004
– volume: 13
  start-page: 1908
  year: 2020
  ident: 2024051503452828000_8.1.e001308.25
  article-title: Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up
  publication-title: Int J Ophthalmol
  doi: 10.18240/ijo.2020.12.10
  contributor:
    fullname: Koentjoro
– ident: 2024051503452828000_8.1.e001308.15
  doi: 10.1016/j.ophtha.2014.08.043
– volume: 30
  start-page: 125
  year: 2019
  ident: 2024051503452828000_8.1.e001308.13
  article-title: New developments in tube shunt surgery
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0000000000000549
  contributor:
    fullname: Chen
– ident: 2024051503452828000_8.1.e001308.5
  doi: 10.5694/mja2.50020
– ident: 2024051503452828000_8.1.e001308.7
  doi: 10.1016/j.survophthal.2004.10.006
– ident: 2024051503452828000_8.1.e001308.6
  doi: 10.1001/jama.2020.21899
– volume: 16
  start-page: 83
  year: 2016
  ident: 2024051503452828000_8.1.e001308.26
  article-title: The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis
  publication-title: BMC Ophthalmol
  doi: 10.1186/s12886-016-0265-6
  contributor:
    fullname: Wang
SSID ssj0001916426
Score 2.273017
Snippet ObjectiveTo compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and...
To compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm (BGI-250), or Baerveldt-350mm (BGI-350) implantation. Retrospective cohort study comprising...
OBJECTIVETo compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation. METHODS AND...
Objective To compare outcomes following Ahmed-FP7 (AGI-FP7), Baerveldt-250mm2 (BGI-250), or Baerveldt-350mm2 (BGI-350) implantation.Methods and analysis...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
bmj
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e001308
SubjectTerms Cataracts
Cohort analysis
Corneal transplantation
Electronic Health Records
Follow-Up Studies
Glaucoma
Glaucoma - surgery
Glaucoma Drainage Implants
Humans
Intraocular Pressure
Patients
Postoperative Complications - surgery
Prosthesis Implantation - methods
Retrospective Studies
Surgeons
Surgery
Surgical outcomes
Text analysis
Treatment Outcome
Treatment Surgery
Variance analysis
Vision
Visual Acuity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QF8Sa0ICNx4WA1iZ_h1pauegEhARK3yIltFrRNqk1y4O_wSztjZ7e7CKkXjutYkdczk5nxeL6PkLdc5a3TwbFKGMFEEZDIvQys4eCrjQnOR5Ckiy_603fz4RxhcrZUX3gnLMEDp407NqowVamlxhpdA_F5K8rGuVz63CtwOPHrm6udZCqerkDUA75n7pUruDpuLn_1V8txyZAvnMWCHbakwPCeR4rA_f-KNv--NLnjhRYPyYM5fKQnadmPyB3fPSb3Ps4F8ifkz1niFex-0JMlvIYtPms69vTU4s3GlRsZBCPUdm5nhMPIMK3jJ5D20wg66If3tGC_wQoopOPTahwo9qFQCz_Hdb9pz6RIr7seacSopSsPZhFJjyhElfSGYIemZkuaDoSekm-L869nF2ymYWCw3XxktrLWBwS-M7LNg6oCEoX6otVFqKwwlsvKSQd5jFLWOi2DzIUo21Ao2xZa82fkoOs7_4JQ1SjtcxMgZ6qE5M6WodVaShfARzoVMvIOBFLPZjTUMUPhqt4Ir0bh1Ul4GWEbsdVXCZnjlvmnKNvtXMTVjgOgbfWsbfVt2paRo41m3KwSi9FCcIi1M_Jm-xjMFGsvtvP9hHOwxFxyKTLyPCnSdiVcwz5DnJQRs6die0vdf9L9XEYocEimkSrLvPwff-6Q3E_GgWdMR-RgXE_-Fbk7uOl1tK5rj9MnRw
  priority: 102
  providerName: Directory of Open Access Journals
Title Comparing Ahmed-FP7 to Baerveldt-250 and Baerveldt-350 surgical outcomes: 1-year results from a retrospective cohort study leveraging the electronic health record
URI http://dx.doi.org/10.1136/bmjophth-2023-001308
https://www.ncbi.nlm.nih.gov/pubmed/37493661
https://www.proquest.com/docview/2829443099
https://search.proquest.com/docview/2842452354
https://pubmed.ncbi.nlm.nih.gov/PMC10410868
https://doaj.org/article/8618927570424b499c42bdd05e0e6023
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYHhAXxJtAqYzEhYO7SfwMt3bpqpeiSoDELXJiu9tqN1nlceDv8EsZO8l2FyEhcYzjWE5mJjPjeXwIfaAiLo10hmRMMcIS54HcU0cKCrpaKWdsaJJ0-VV--aE-X_g2OWKqhQlJ-2Vxe1qtN6fV7SrkVm435XzKE5tfXy3AhfAAQWo-QzMwDvd89HCyAhYP6J2xTi6hYl5s7urtqlsRjxVOQrDO4_RRyTIqfHvsGcw4UEyhf__fjM4_cyf3lNHyCXo8WpH4bNjtU_TAVs_Qw6sxTv4c_VoM8ILVDT5bwTJkeS1xV-Nz7RMc16YjYJNgXZm9EQojbd-EPyGu-w5Y0bafcEJ-gjBg8Mr7dddiX46CNVx2TT1VaWKPstt0OLSqxWsL0hGwjzAYl_geZwcPNZd4OBd6gb4vL74tLsmIxkAK-Ewd0ZnW1vn-d4qXsROZ83ihNill4jLNlKY8M9yAOyOE1kZyx2PG0tIlQpeJlPQlOqrqyr5GWBRC2lg5cJ0yxqnRqSul5Nw4UJVGuAh9BILkozS1eXBUqMgnOuaejvlAxwiRiWz5dmjQ8Y_55562u7m-vXYYqJubfGSyXIlEZank0geG4fWzkqWFMTG3sRWwVoSOJ86436WPSTNGweSO0PvdbZBWH4LRla17P8dHmlPKWYReDYy028nEjhFSByx2sNXDOyAgoSP4JBBv_v_Rt-jRIB3-gOkYHXVNb9-hWWv6k3BOcRKE7DdFZyrd
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfokGAXvscCA4zEhYPXJHZsh9tWVhWxTpMYErfIie11qE2qNjnw7_CX8uwkXYuQkHas7bZO_Xt97_l9_BD6QHlYaGE1SZlkhEXWEbnHluQUdLWUVhvfJGnyTVz8kJ_PXJsc3tfC-KT9Ir85LueL4_Jm5nMrl4ti2OeJDS-nI3AhHEGQHA7QfRDYMNzy0v3dCtg8oHm6SrmI8mG--FktZ_WMOLZw4sN1jqmPCpZS7hpkD2DFjmryHfz_ZXb-nT25pY7Gj-_6IE_Qo84AxSft_FN0z5TP0INpF2J_jn6PWmbC8hqfzOD7yfhS4LrCp8rlRs51TcCcwarUWyMURtbNyv-J4qqpAcVm_QlH5BfIEQaHvpnXa-wqWbCCl_Wq6gs8sSPoXdXYd7nFcwOC5WmTMNil-JaiB7flmri9UnqBvo_PrkYT0hE5kBx-35qoVCljXes8mRSh5al1VKMmKkRkU8WkokmqEw2eEOdKaZHYJGQsLmzEVREJQQ_QXlmV5hBhnnNhQmnB60pZQrWKbSFEkmgLWlZzG6CPcJJZJ4jrzPs4lGc9ADIHgKwFQIBIf97Zsu3t8Z_1pw4Um7WuM7cfqFbXWXesmeSRTGORCBdThsdPCxbnWoeJCQ2HzwrQUQ-p2126cDZjFKz1AL3fTIOgu-iNKk3VuDUuSB3ThAXoZYvAzU56HAdI7mBzZ6u7MwBJ30y8h-Cru7_1HXo4uZqeZ-dfLr6-RvutiLl7qiO0V68a8wYN1rp562X0D92OP50
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELbokCZe-M0IDDASLzx4TWLHdva2dauGYFMlQOItcmJ7HWqTKk0e-Hf4Szk7SdciJCR4rHOpnPi73J3Pdx9C7ygPCy2sJimTjLDIOiL32JKcgq2W0mrjmyRdfBZX3-TZuWuTczzUwvhD-0V-c1QulkflzdyfrVwti_FwTmw8u5xACOEIguR4pe14hO6C0obxVqTu91fA7wHr01fLRZSP8-X3ajVv5sQxhhOfsnNsfVSwlHLXJHsEEjvmyXfx_5Pr-fsJyi2TNH3wPw_zEN3vHVF80sk8QndM-RjtX_ap9ifo56RjKCyv8ckc5kCmM4GbCp8qd0ZyoRsCbg1Wpd4aoTCybmv_McVV2wCazfoYR-QH6BOGwL5dNGvsKlqwgp9NXQ2FntgR9dYN9t1u8cKAgnn6JAz-Kb6l6sFd2Sbutpaeoq_T8y-TC9ITOpAc3nFDVKqUsa6FnkyK0PLUOspRExUisqliUtEk1YmGiIhzpbRIbBIyFhc24qqIhKDP0F5ZleY5wjznwoTSQvSVsoRqFdtCiCTRFqyt5jZA72E1s14h15mPdSjPBhBkDgRZB4IAkWHNs1XX4-Mv8qcOGBtZ16HbD1T1ddYvbSZ5JNNYJMLlluHx04LFudZhYkLD4b8CdDjA6naWLq3NGAWvPUBvN5dB4V0WR5Wmap2MS1bHNGEBOuhQuJnJgOUAyR187kx19wrA0jcVH2D44t9vfYP2Z2fT7NOHq48v0b1Oy9x21SHaa-rWvEKjtW5fezX9BdooQh0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparing+Ahmed-FP7+to+Baerveldt-250+and+Baerveldt-350+surgical+outcomes%3A+1-year+results+from+a+retrospective+cohort+study+leveraging+the+electronic+health+record&rft.jtitle=BMJ+open+ophthalmology&rft.au=Shen%2C+Leo+L&rft.au=Guo%2C+Xinxing&rft.au=Johnson%2C+Thomas+V&rft.au=Friedman%2C+David&rft.date=2023-06-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=2397-3269&rft.eissn=2397-3269&rft.volume=8&rft.issue=1&rft.spage=e001308&rft_id=info:doi/10.1136%2Fbmjophth-2023-001308&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2397-3269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2397-3269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2397-3269&client=summon